Login/Register
The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

IPCA Laboratories

0123456789.01234567890123456789
0.00 (0.00%) 1D
graph errorgraph error

We are having trouble fetching the graph

Retry

NSE
1D
1W
1M
1Y
3Y
5Y
All
Overview
F&O
Events
News

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Analyst Estimates

56%
Buy
6%
Hold
56%
Sell
38%
Aggregated by Refinitiv from 16 Analysts

Fundamentals

Market Cap₹29,138Cr
ROE8.01%
P/E Ratio(TTM)59.20
EPS(TTM)19.40
P/B Ratio4.74
Dividend Yield0.35%
Industry P/E32.29
Book Value242.36
Debt to Equity0.32
Face Value1
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
1,6371,5771,5481,6302,073Sep '22Dec '22Mar '23Jun '23Sep '23
Quarterly
Yearly

About IPCA Laboratories

Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.;
Parent OrganisationIPCA Laboratories Limited
Founded1949
Managing DirectorMr. Pranay Godha
NSE SymbolIPCALAB

Shareholding Pattern

Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Promoters
46.29%
Mutual Funds
30.23%
Foreign Institutions
9.86%
Retail And Others
9.50%
Other Domestic Institutions
4.12%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
34.56
Cipla
NA
(0.00%)
28.21
Dr Reddy's Laboratories
NA
(0.00%)
18.83
Mankind Pharma
NA
(0.00%)
49.31
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
Buy now
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW